AROS Is a Significant Biomarker for Tumor Aggressiveness in Non-cirrhotic Hepatocellular Carcinoma

Despite a low risk of liver failure and preserved liver function, non-cirrhotic hepatocellular carcinoma (HCC) has a poor prognosis. In the current study, we evaluated an active regulator of SIRT1 (AROS) as a prognostic biomarker in non-cirrhotic HCC. mRNA levels of AROS were measured in tumor and n...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Jung-Hee, Ahn, Keun Soo, Moon, Young Ho, Park, Jin Young, Wang, Hee Jung, Choi, Kwan Yong, Kim, Gundo, Joh, Jae Won, Lee, Kyeong Geun, Kang, Koo Jeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553671/
https://www.ncbi.nlm.nih.gov/pubmed/26339164
http://dx.doi.org/10.3346/jkms.2015.30.9.1253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553671/
https://www.ncbi.nlm.nih.gov/pubmed/26339164
http://dx.doi.org/10.3346/jkms.2015.30.9.1253

Ejemplares similares